NASDAQ
76.99USD
0.00 (0.00%)
We have scored 9 news catalysts on Forte Biosciences, Inc. (FBRX) over the past 12 months. The biggest single-day move next to one of them came Jul 27, 2026, when FBRX closed +39.6%: “Crude Oil Falls Sharply; US Durable Goods Orders Increase 0.3% In June”. Coverage across the window leans positive (average ticker sentiment +0.17). Most of the impact sits in short squeeze potential and buyback capacity.
Dots are scored news catalysts — size = impact, color = sentiment. Tap one to read it.
Market cap
1.6B
P/E
—
EPS
—
Beta
2.65
52W range
10.11-77.2
Day range
76.97–76.99
Open
76.97
Prev close
76.99
Volume
0
Avg volume
998.5K
Dividend
0.00
IPO
2017-04-13
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about Forte Biosciences, Inc. — not a sector bucket. Click an edge to see the articles that established the link.
Latest scored catalyst for FBRX: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Forte Biosciences, Inc. is a U.S.-based biopharmaceutical company currently in its clinical development phase. The firm's key initiative involves advancing the FB-102 program, which is designed to tackle a variety of autoimmune conditions, notably vitiligo and alopecia areata. Their main offices are situated in Dallas, Texas.
